PMID- 23841933 OWN - NLM STAT- MEDLINE DCOM- 20131119 LR - 20211203 IS - 1471-4159 (Electronic) IS - 0022-3042 (Linking) VI - 127 IP - 1 DP - 2013 Oct TI - AMP-activated protein kinase counteracts brain-derived neurotrophic factor-induced mammalian target of rapamycin complex 1 signaling in neurons. PG - 66-77 LID - 10.1111/jnc.12362 [doi] AB - Growth factors and nutrients, such as amino acids and glucose, regulate mammalian target of rapamycin complex 1 (mTORC1) signaling and subsequent translational control in a coordinated manner. Brain-derived neurotrophic factor (BDNF), the most prominent neurotrophic factor in the brain, activates mTORC1 and induces phosphorylation of its target, p70S6 kinase (p70S6K), at Thr389 in neurons. BDNF also increases mammalian target of rapamycin-dependent novel protein synthesis in neurons. Here, we report that BDNF-induced p70S6K activation is dependent on glucose, but not amino acids, sufficiency in cultured cortical neurons. AMP-activated protein kinase (AMPK) is the molecular background to this specific nutrient dependency. Activation of AMPK, which is induced by glucose deprivation, treatment with pharmacological agents such as 2-deoxy-D-glucose, metformin, and 5-aminoimidazole-4-carboxamide ribonucleoside or forced expression of a constitutively active AMPKalpha subunit, counteracts BDNF-induced phosphorylation of p70S6K and enhanced protein synthesis in cortical neurons. These results indicate that AMPK inhibits the effects of BDNF on mTORC1-mediated translation in neurons. CI - (c) 2013 International Society for Neurochemistry. FAU - Ishizuka, Yuta AU - Ishizuka Y AD - Department of Molecular Neurobiology, Brain Research Institute, Niigata University, Niigata, Japan; Department of Neurobiology and Behavior, Gunma University Graduate School of Medicine, Gunma, Japan. FAU - Kakiya, Naomasa AU - Kakiya N FAU - Witters, Lee A AU - Witters LA FAU - Oshiro, Noriko AU - Oshiro N FAU - Shirao, Tomoaki AU - Shirao T FAU - Nawa, Hiroyuki AU - Nawa H FAU - Takei, Nobuyuki AU - Takei N LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130729 PL - England TA - J Neurochem JT - Journal of neurochemistry JID - 2985190R RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Hypoglycemic Agents) RN - 0 (Multiprotein Complexes) RN - 9100L32L2N (Metformin) RN - 9G2MP84A8W (Deoxyglucose) RN - AE28F7PNPL (Methionine) RN - EC 2.7.11.1 (Mechanistic Target of Rapamycin Complex 1) RN - EC 2.7.11.1 (Oncogene Protein v-akt) RN - EC 2.7.11.1 (Ribosomal Protein S6 Kinases, 70-kDa) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 2.7.11.31 (AMP-Activated Protein Kinases) RN - IY9XDZ35W2 (Glucose) SB - IM MH - AMP-Activated Protein Kinases/*physiology MH - Animals MH - Brain-Derived Neurotrophic Factor/*pharmacology MH - Cells, Cultured MH - Cerebral Cortex/cytology/drug effects/metabolism MH - Deoxyglucose/pharmacology MH - Electrophoresis, Polyacrylamide Gel MH - Electroporation MH - Fibroblasts/metabolism MH - Glucose/deficiency/physiology MH - Hypoglycemic Agents/pharmacology MH - Immunohistochemistry MH - Immunoprecipitation MH - Mechanistic Target of Rapamycin Complex 1 MH - Metformin/pharmacology MH - Methionine/metabolism MH - Multiprotein Complexes/*physiology MH - Neurons/*drug effects MH - Oncogene Protein v-akt/metabolism MH - Phosphorylation MH - Rats MH - Rats, Sprague-Dawley MH - Ribosomal Protein S6 Kinases, 70-kDa/metabolism MH - Signal Transduction/*drug effects MH - TOR Serine-Threonine Kinases/*physiology OTO - NOTNLM OT - AMPK OT - BDNF OT - mTOR OT - neuron OT - protein synthesis OT - translation EDAT- 2013/07/12 06:00 MHDA- 2013/11/20 06:00 CRDT- 2013/07/12 06:00 PHST- 2013/06/07 00:00 [received] PHST- 2013/07/04 00:00 [revised] PHST- 2013/07/05 00:00 [accepted] PHST- 2013/07/12 06:00 [entrez] PHST- 2013/07/12 06:00 [pubmed] PHST- 2013/11/20 06:00 [medline] AID - 10.1111/jnc.12362 [doi] PST - ppublish SO - J Neurochem. 2013 Oct;127(1):66-77. doi: 10.1111/jnc.12362. Epub 2013 Jul 29.